Skin fibroblasts of patients with geleophysic dysplasia due to FBN1 mutations have lysosomal inclusions and losartan improves their microfibril deposition defect
Abstract Background Geleophysic dysplasia (GPHYSD) is a disorder characterized by dysmorphic features, stiff joints and cardiac involvement due to defects of TGF‐β signaling. GPHYSD can be caused by mutations in FBN1, ADAMTLS2, and LTBP3 genes. Methods and Results Consistent with previous reports, w...
Main Authors: | Pasquale Piccolo, Valeria Sabatino, Pratibha Mithbaokar, Elena Polishchuk, John Hicks, Roman Polishchuk, Carlos A. Bacino, Nicola Brunetti‐Pierri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.844 |
Similar Items
-
A Review of Three Chinese Cases of Acromicric/Geleophysic Dysplasia with FBN1 Mutations
by: Shan YC, et al.
Published: (2021-05-01) -
Geleophysic dysplasia: novel missense variants and insights into ADAMTSL2 intracellular trafficking
by: Pasquale Piccolo, et al.
Published: (2019-12-01) -
Geleophysic dysplasia associated with bilateral angle closure glaucoma
by: Murat Sinan Saricaoglu, et al.
Published: (2013-01-01) -
Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01) -
The Effects of Telmisartan and Losartan on Insulin Sensitivity
by: Okan Bakıner, et al.
Published: (2013-12-01)